We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Genomic Analysis of Kitasatospora setae to Explore Its Biosynthetic Potential Regarding Secondary Metabolites.
- Authors
Xue, Yutong; Zhou, Zhiyan; Feng, Fangjian; Zhao, Hang; Tan, Shuangling; Li, Jinling; Wu, Sitong; Ju, Zhiran; He, Shan; Ding, Lijian
- Abstract
Actinomycetes have long been recognized as important sources of clinical antibiotics. However, the exploration of rare actinomycetes, despite their potential for producing bioactive molecules, has remained relatively limited compared to the extensively studied Streptomyces genus. The extensive investigation of Streptomyces species and their natural products has led to a diminished probability of discovering novel bioactive compounds from this group. Consequently, our research focus has shifted towards less explored actinomycetes, beyond Streptomyces, with particular emphasis on Kitasatospora setae (K. setae). The genome of K. setae was annotated and analyzed through whole-genome sequencing using multiple bio-informatics tools, revealing an 8.6 Mbp genome with a 74.42% G + C content. AntiSMASH analysis identified 40 putative biosynthetic gene clusters (BGCs), approximately half of which were recessive and unknown. Additionally, metabolomic mining utilizing mass spectrometry demonstrated the potential for this rare actinomycete to generate numerous bioactive compounds such as glycosides and macrolides, with bafilomycin being the major compound produced. Collectively, genomics- and metabolomics-based techniques confirmed K. setae's potential as a bioactive secondary metabolite producer that is worthy of further exploration.
- Subjects
GENOMICS; METABOLITES; SETAE; WHOLE genome sequencing; GENE clusters
- Publication
Antibiotics (2079-6382), 2024, Vol 13, Issue 5, p459
- ISSN
2079-6382
- Publication type
Article
- DOI
10.3390/antibiotics13050459